<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00865527</url>
  </required_header>
  <id_info>
    <org_study_id>CTC1.0</org_study_id>
    <nct_id>NCT00865527</nct_id>
  </id_info>
  <brief_title>Pilot Study of Colon Cancer Screening Tests</brief_title>
  <official_title>Randomized Comparison of Virtual Colonoscopy, Optical Colonoscopy, and Fecal Occult Blood Testing for Colorectal Cancer Screening: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colon cancer is the second leading cause of cancer death in North America. These deaths are
      preventable with proper screening. Fecal occult blood testing, virtual colonoscopy, and
      standard (optical) colonoscopy are all options for colon cancer screening, but it is not
      known which is the best at preventing death from colon cancer. A large study comparing these
      three tests is desperately needed. In this pilot study, the investigators want to find out
      what percentage of patients will show up for their screening test once enrolled. This will
      provide crucial information for the successful execution of the larger study.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of ongoing funding
  </why_stopped>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of enrolled patients who attend for their assigned screening test</measure>
    <time_frame>Immediate</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of non-responders to mailed invitations, who respond to telephone or mail reminders.</measure>
    <time_frame>Immediate</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring polypectomy after virtual colonoscopy who receive same or next day optical colonoscopy for polypectomy</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects who cross over to another arm of the study</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients found to have an advanced adenoma</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients found to have invasive colorectal carcinoma</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">198</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Colon Cancer</condition>
  <condition>Adenomatous Polyps</condition>
  <arm_group>
    <arm_group_label>Fecal Occult Blood Test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fecal occult blood test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Virtual Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>virtual colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optical Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>optical (conventional / endoscopic) colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fecal occult blood test</intervention_name>
    <description>FOBT</description>
    <arm_group_label>Fecal Occult Blood Test</arm_group_label>
    <other_name>FOBT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Virtual colonoscopy</intervention_name>
    <description>computed tomographic colonography</description>
    <arm_group_label>Virtual Colonoscopy</arm_group_label>
    <other_name>CT colonography</other_name>
    <other_name>computed tomographic colonography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Optical colonoscopy</intervention_name>
    <description>optical (conventional / endoscopic) colonoscopy</description>
    <arm_group_label>Optical Colonoscopy</arm_group_label>
    <other_name>Colonoscopy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All individuals age 50 to 70 years

        Exclusion Criteria:

          -  Unable to give informed consent

          -  History of colorectal cancer

          -  History of adenomatous polyp

          -  History of inflammatory bowel disease

          -  Prior participation in FOBT screening

          -  Prior refusal to participate in FOBT screening

          -  Flexible sigmoidoscopy within the previous 3 years

          -  Virtual colonoscopy within the previous 3 years

          -  Optical colonoscopy within the previous 3 years

          -  Severe of terminal illness that would preclude benefit from colon cancer screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John J You, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2009</study_first_submitted>
  <study_first_submitted_qc>March 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2009</study_first_posted>
  <last_update_submitted>March 29, 2016</last_update_submitted>
  <last_update_submitted_qc>March 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McMaster University</investigator_affiliation>
    <investigator_full_name>John You</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Colorectal cancer</keyword>
  <keyword>Colon cancer</keyword>
  <keyword>Adenomatous polyps</keyword>
  <keyword>Screening</keyword>
  <keyword>Fecal occult blood test</keyword>
  <keyword>Computed tomographic colonography</keyword>
  <keyword>Colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Adenomatous Polyps</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

